Cart
sales@molnova.com
Nandrolone phenpropionate
CAS No. 62-90-8
Nandrolone phenpropionate( —— )
Catalog No. M22550 CAS No. 62-90-8
Nandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 33 | In Stock |
|
| 25MG | 50 | In Stock |
|
| 50MG | 71 | In Stock |
|
| 100MG | 104 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNandrolone phenpropionate
-
NoteResearch use only, not for human use.
-
Brief DescriptionNandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.
-
DescriptionNandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
Recptorandrogen receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62-90-8
-
Formula Weight406.6
-
Molecular FormulaC27H34O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kahn S B , Conroy J F , Brodsky I . Effect of nandrolone phenpropionate on myelopoiesis[J]. Journal of Medicine, 1974, 5(6):303.
molnova catalog
related products
-
RU 59063
RU 59063 is a prototype of a new class of high-affinity nonsteroidal androgen receptor (AR) ligands.
-
JNJ-63576253
JNJ-63576253 is a potent and orally active full antagonist of androgen receptor (AR), with IC50s of 37 and 54 nM for F877L mutant AR and wild-type AR in LNCaP cells.?
-
LGD-4033
A novel nonsteroidal, oral selective androgen receptor modulator (SARM), binds androgen receptor with high affinity (Ki=1 nM) and selectivity.
